GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Monday reported a loss of $31.3 million in its fourth quarter.
The Gaithersburg, Maryland-based company said it had a loss of 58 cents per share. Earnings, adjusted for non-recurring costs, came to 5 cents per share.
The biopharmaceutical company posted revenue of $194.7 million in the period.
For the current quarter ending in March, Emergent Biosolutions said it expects revenue in the range of $200 million to $240 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。